SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients

SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients

<b>Background/Objectives:</b> Patients suffering from inflammatory bowel diseases (IBDs) undergoing treatment with anti-TNF antibodies mount a diminished humoral immune response to vaccination against SARS-CoV-2 compared to healthy controls. The characterization of variant-specific immun...

Full description

Saved in:
Bibliographic Details
Main Authors: Eva Ulla Lorentzen, Richard Vollenberg, Rieke Neddermeyer, Michael Schoefbaenker, Eike R. Hrincius, Stephan Ludwig, Phil-Robin Tepasse, Joachim Ewald Kuehn
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Vaccines
Subjects:
SARS-CoV-2
IBD patients
anti-TNF therapy
vaccination
humoral immune response
variant-specific antibodies
Online Access:https://www.mdpi.com/2076-393X/13/6/595
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items